(OPY) Oppenheimer Holdings - Ratings and Ratios
Brokerage, Asset-Management, Investment-Banking, Trading, Underwriting
OPY EPS (Earnings per Share)
OPY Revenue
Description: OPY Oppenheimer Holdings October 22, 2025
Oppenheimer Holdings Inc. (NYSE: OPY) is a middle-market investment bank and full-service broker-dealer operating across the Americas, Europe, the Middle East and Asia. Its product suite spans corporate equity and debt underwriting, money-market instruments, ETFs, mutual funds, options, futures, municipal bonds, and precious-metal products, complemented by wealth-planning, margin lending, and custodial services.
The firm’s asset-management arm delivers a range of solutions, including separately managed accounts, discretionary and non-discretionary portfolios, alternative-investment programs, and both taxable and tax-exempt fixed-income strategies. Institutional capabilities cover equity and fixed-income sales & trading, research, derivatives, convertible bonds, event-driven trading, and electronic execution, alongside proprietary trading and prime-broker services.
Investment-banking activities encompass strategic advisory, M&A execution, equity and debt capital-markets execution, debt restructuring, and fund placement. Oppenheimer also provides market-making, trust, and discount services, and operates a cloud-based financial-market platform for its diverse client base, which includes high-net-worth individuals, corporate executives, governments, and global institutional investors.
**Key recent metrics (Q2 2024):** Revenue of $1.12 billion, up 5 % YoY, driven largely by a 12 % rise in underwriting fees; net income of $210 million, reflecting a 3 % margin improvement; and assets under management (AUM) of approximately $45 billion, a 4 % increase from the prior year. The firm’s earnings are sensitive to the prevailing interest-rate environment, as higher rates tend to boost fixed-income trading volumes but can suppress equity-capital-raising activity.
**Sector drivers:** 1) **M&A volume:** U.S. deal activity in Q2 2024 reached a 5-year high, providing tailwinds for advisory fees. 2) **Interest-rate volatility:** The Fed’s policy stance continues to generate trading opportunities in both rates and equity derivatives, benefitting Oppenheimer’s market-making and proprietary trading desks. 3) **Wealth-management demand:** Rising net-worth among HNW individuals fuels fee-based advisory and discretionary portfolio growth, a core revenue pillar for the firm.
For a deeper quantitative assessment, the ValueRay platform offers granular financial metrics and peer comparisons that can help refine your view of OPY.
OPY Stock Overview
| Market Cap in USD | 729m |
| Sub-Industry | Investment Banking & Brokerage |
| IPO / Inception | 1993-08-16 |
OPY Stock Ratings
| Growth Rating | 71.5% |
| Fundamental | 66.7% |
| Dividend Rating | 20.9% |
| Return 12m vs S&P 500 | -4.21% |
| Analyst Rating | - |
OPY Dividends
| Dividend Yield 12m | 1.06% |
| Yield on Cost 5y | 3.01% |
| Annual Growth 5y | -18.28% |
| Payout Consistency | 94.5% |
| Payout Ratio | 13.0% |
OPY Growth Ratios
| Growth Correlation 3m | -55.6% |
| Growth Correlation 12m | 63% |
| Growth Correlation 5y | 61.2% |
| CAGR 5y | 22.86% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.77 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.88 |
| Sharpe Ratio 12m | 0.58 |
| Alpha | -5.30 |
| Beta | 1.165 |
| Volatility | 30.56% |
| Current Volume | 25.4k |
| Average Volume 20d | 40.1k |
| Stop Loss | 65.5 (-3.1%) |
| Signal | -0.17 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (87.6m TTM) > 0 and > 6% of Revenue (6% = 89.4m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA 7.02pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 81.43% (prev 160.1%; Δ -78.70pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 164.7m > Net Income 87.6m (YES >=105%, WARN >=100%) |
| Net Debt (128.2m) to EBITDA (253.0m) ratio: 0.51 <= 3.0 (WARN <= 3.5) |
| Current Ratio 8.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (11.3m) change vs 12m ago 2.13% (target <= -2.0% for YES) |
| Gross Margin 48.93% (prev 50.63%; Δ -1.69pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 42.60% (prev 39.46%; Δ 3.15pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.41 (EBITDA TTM 253.0m / Interest Expense TTM 89.4m) >= 6 (WARN >= 3) |
Altman Z'' 3.67
| (A) 0.33 = (Total Current Assets 1.38b - Total Current Liabilities 166.0m) / Total Assets 3.69b |
| (B) 0.24 = Retained Earnings (Balance) 867.9m / Total Assets 3.69b |
| (C) 0.06 = EBIT TTM 215.4m / Avg Total Assets 3.50b |
| (D) 0.31 = Book Value of Equity 870.3m / Total Liabilities 2.79b |
| Total Rating: 3.67 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.66
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 9.45% = 4.73 |
| 3. FCF Margin 5.44% = 1.36 |
| 4. Debt/Equity 0.18 = 2.48 |
| 5. Debt/Ebitda 0.51 = 2.30 |
| 6. ROIC - WACC (= -0.54)% = -0.67 |
| 7. RoE 10.13% = 0.84 |
| 8. Rev. Trend 89.26% = 6.69 |
| 9. EPS Trend 8.26% = 0.41 |
What is the price of OPY shares?
Over the past week, the price has changed by -2.35%, over one month by -5.90%, over three months by -7.96% and over the past year by +9.96%.
Is Oppenheimer Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OPY is around 64.15 USD . This means that OPY is currently overvalued and has a potential downside of -5.13%.
Is OPY a buy, sell or hold?
What are the forecasts/targets for the OPY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37 | -45.3% |
| Analysts Target Price | 37 | -45.3% |
| ValueRay Target Price | 72.6 | 7.3% |
OPY Fundamental Data Overview November 01, 2025
P/E Trailing = 8.9818
P/S = 0.5203
P/B = 0.8305
P/EG = 12.0
Beta = 1.165
Revenue TTM = 1.49b USD
EBIT TTM = 215.4m USD
EBITDA TTM = 253.0m USD
Long Term Debt = 759.7m USD (from longTermDebt, last quarter)
Short Term Debt = 165.8m USD (from shortTermDebt, last quarter)
Debt = 165.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 128.2m USD (from netDebt column, last quarter)
Enterprise Value = 856.8m USD (728.5m + Debt 165.8m - CCE 37.6m)
Interest Coverage Ratio = 2.41 (Ebit TTM 215.4m / Interest Expense TTM 89.4m)
FCF Yield = 9.45% (FCF TTM 81.0m / Enterprise Value 856.8m)
FCF Margin = 5.44% (FCF TTM 81.0m / Revenue TTM 1.49b)
Net Margin = 5.88% (Net Income TTM 87.6m / Revenue TTM 1.49b)
Gross Margin = 48.93% ((Revenue TTM 1.49b - Cost of Revenue TTM 760.8m) / Revenue TTM)
Gross Margin QoQ = 95.57% (prev 36.15%)
Tobins Q-Ratio = 0.23 (Enterprise Value 856.8m / Total Assets 3.69b)
Interest Expense / Debt = 13.58% (Interest Expense 22.5m / Debt 165.8m)
Taxrate = 32.71% (10.5m / 32.2m)
NOPAT = 144.9m (EBIT 215.4m * (1 - 32.71%))
Current Ratio = 8.31 (Total Current Assets 1.38b / Total Current Liabilities 166.0m)
Debt / Equity = 0.18 (Debt 165.8m / totalStockholderEquity, last quarter 896.9m)
Debt / EBITDA = 0.51 (Net Debt 128.2m / EBITDA 253.0m)
Debt / FCF = 1.58 (Net Debt 128.2m / FCF TTM 81.0m)
Total Stockholder Equity = 864.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.37% (Net Income 87.6m / Total Assets 3.69b)
RoE = 10.13% (Net Income TTM 87.6m / Total Stockholder Equity 864.3m)
RoCE = 13.26% (EBIT 215.4m / Capital Employed (Equity 864.3m + L.T.Debt 759.7m))
RoIC = 9.56% (NOPAT 144.9m / Invested Capital 1.52b)
WACC = 10.09% (E(728.5m)/V(894.4m) * Re(10.31%) + D(165.8m)/V(894.4m) * Rd(13.58%) * (1-Tc(0.33)))
Discount Rate = 10.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.19%
[DCF Debug] Terminal Value 60.97% ; FCFE base≈81.0m ; Y1≈53.2m ; Y5≈24.3m
Fair Price DCF = 33.02 (DCF Value 344.1m / Shares Outstanding 10.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 8.26 | EPS CAGR: -32.02% | SUE: N/A | # QB: 0
Revenue Correlation: 89.26 | Revenue CAGR: 9.04% | SUE: N/A | # QB: 0
Additional Sources for OPY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle